July 12th 2021, 6:00pm
This edition of HCPLive® State of the Science involves 3 experts discussing different trends in IBD treatments and care.
July 12th 2021, 10:00am
The virtual sessions will cover a litany of topics in the greater spectrum of cardiovascular disease prevention and care.
July 1st 2021, 8:00pm
Dennis Bruemmer, MD discusses new agents and perspectives on care in treating patients with type 2 diabetes at high risk of CV, renal complications.
July 1st 2021, 4:00pm
Investigators say that dietary habits in youth and young adult patients with diabetes can be impacted by income, employment, ethnicity, and a variety of other factors.
July 1st 2021, 1:00pm
The treatment resulted in a significant reduction in expression of genes representing T & B lymphocytes, plasma cells/plasmablasts, and myeloid cells.
July 1st 2021, 10:00am
Elaine M. Apperson discusses treating diabetes in a pediatric population, including diabetes burnout, the effects of food deserts, and the consequences of COVID-19 on treatment.
June 30th 2021, 7:00pm
Data show event rates varied two-fold across regions, with risk reduction of T2D and CKD events across geographic regions without heterogeneity.
June 30th 2021, 4:00pm
Part 2 of a Q&A with Elena Christofides, MD highlighting important discussions surrounding ADA 2021, including semaglutide and obesity treatments as they relate to T2D.
June 30th 2021, 1:00pm
Researchers push for transparency between health care professionals and patients with diabetes about the safety and efficacy of the influenza vaccine
June 29th 2021, 10:00pm
In part 1 of a Q&A, Elena Christofides, MD highlights important discussions surrounding ADA 2021, including cardiometabolic medicine and risk factors for T1D.